|Welch Center core faculty member Dr. Elizabeth Selvin has received a grant from the National Institute of Diabetes andDigestive and Kidney Diseases to fund a two-year study investigating the clinical relevance of normal and pre-diabetic HbA1c values. The project is an ancillary study to the Atherosclerosis Risk in Communities (ARIC) Study.|
Dr. Selvin’s study will examine the importance of Hemoglobin A1c (HbA1c) in predicting diabetes and other important clinical outcomes (including cardiovascular disease, eye disease, kidney disease, cancer, and heart failure) prior to the onset of diabetes. This research will provide important information regarding the use of HbA1c as a screening test for diabetes and the clinical relevance of HbA1c levels in persons prior to a diagnosis of diabetes.
The grant furthers Dr. Selvin’s particular research interest in the interface of epidemiology and clinical and public health policy, especially with respect to how epidemiologic research can inform diabetes, cardiovascular disease, and kidney disease screening, diagnosis, and treatment.